Showing results (51-60 of 172) with videos related to
Sort By:
Pageof 18
International Journal of Radiation Oncology, Biology, Physics|November 1, 2011
Feasibility and acute toxicity of hypofractionated radiation in large-breasted patientsPaige L Dorn, Kimberly S Corbin, Hania Al-Hallaq, et al.Frontiers in Oncology|October 5, 2017
Radiotherapy for Oligometastatic Lung CancerDerek P Bergsma, Joseph K Salama, Deepinder P Singh, et al.Expert Review of Anticancer Therapy|April 15, 2016
Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting?Michael W Drazer, Joseph K Salama, Olwen M Hahn, et al.Dalton Transactions (Cambridge, England : 2003)|February 8, 2006
Group 4 complexes of amine bis(phenolate)s and their application for the ring opening polymerisation of cyclic estersAmanda J Chmura, Matthew G Davidson, Matthew D Jones, et al.Chemical Communications (Cambridge, England)|April 5, 2008
Highly active and stereoselective zirconium and hafnium alkoxide initiators for solvent-free ring-opening polymerization of rac-lactideAmanda J Chmura, Matthew G Davidson, Catherine J Frankis, et al.Expert Review of Anticancer Therapy|November 5, 2015
The evolving role of radiotherapy in treatment of oligometastatic NSCLCDerek P Bergsma, Joseph K Salama, Deepinder P Singh, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 5, 2002
Electrophilic chelating agents for irreversible binding of metal chelates to engineered antibodiesA J Chmura, Brian D Schmidt, Donald T Corson, et al.Biochemistry|June 20, 1998
Mapping the promoter DNA sites proximal to conserved regions of sigma 70 in an Escherichia coli RNA polymerase-lacUV5 open promoter complexJ T Owens, A J Chmura, K Murakami, et al.Journal of Molecular Recognition : JMR|October 3, 2003
Molecular tools for targeted imaging and therapy of cancerClaude F Meares, A J Chmura, Molly S Orton, et al.Practical Radiation Oncology|October 4, 2021
Evaluation of Dose Distribution to Organs-at-Risk in a Prospective Phase 1 Trial of Pembrolizumab and Multisite Stereotactic Body Radiation Therapy (SBRT)Annie Xiao, Jason J Luke, Julien Partouche, et al.Pageof 18